In a study using human and murine HR-deficient pancreatic ductal adenocarcinoma (PDAC) in vitro models, POLQ knockdown was shown to elicit synthetic lethality and induced DNA damage in HR-deficient tumour cells while simultaneously stimulating an immune response by activating the STING signalling pathway [104]. Here, POLQ is linked to neoplasm.